Multidrug-Resistant Campylobacter jejuni Outbreak Linked to Puppy Exposure — United States, 2016–2018
Weekly / September 21, 2018 / 67(37);1032–1035
Martha P. Montgomery, MD1,2; Scott Robertson, DVM2,3; Lia Koski, MPH3,4; Ellen Salehi, MPH1; Lauren M. Stevenson, MHS3,5; Rachel Silver, MPH3,4; Preethi Sundararaman, MPH3,6; Amber Singh, DVM1; Lavin A. Joseph, MS3; Mary Beth Weisner7; Eric Brandt1; Melanie Prarat, MS7; Rick Bokanyi, PhD1; Jessica C. Chen, PhD3,8; Jason P. Folster, PhD3; Christy T. Bennett3,8; Louise K. Francois Watkins, MD3; Rachael D. Aubert, PhD3; Alvina Chu, MHS9; Jennifer Jackson, MPH9; Jason Blanton, PhD10; Amber Ginn10; Kirtana Ramadugu, MPH10; Danielle Stanek, DVM10; Jamie DeMent, MNS10; Jing Cui, DVM7; Yan Zhang, DVM, PhD7; Colin Basler, DVM3; Cindy R. Friedman, MD3; Aimee L. Geissler, PhD3; Samuel J. Crowe, PhD3; Natasha Dowell, MPH3,8; Staci Dixon, MA3; Laura Whitlock, MPH3; Ian Williams, PhD3; Michael A. Jhung, MD3; Megin C. Nichols, DVM3; Sietske de Fijter, MS1; Mark E. Laughlin, DVM3 (View author affiliations)View suggested citation
What is already known about this topic?
Dogs, especially puppies, are a known source of sporadic Campylobacter infections in humans, but are uncommonly reported to cause outbreaks.
What is added by this report?
Investigation of a multistate, multidrug-resistant outbreak of Campylobacter jejuni infections implicated puppies from breeders and distributors sold through pet stores as the outbreak source. Outbreak strains were resistant to all antibiotics commonly used to treat Campylobacter infections.
What are the implications for public health practice?
Consumers, employees, and clinicians should be aware of the risk for disease transmission from puppies, including the possibility of exposure to multidrug-resistant pathogens. Greater adherence to implementation of antibiotic stewardship practices in the commercial dog industry might be needed.
Views equals page views plus PDF downloads
Campylobacter causes an estimated 1.3 million diarrheal illnesses in the United States annually (1). In August 2017, the Florida Department of Health notified CDC of six Campylobacter jejuni infections linked to company A, a national pet store chain based in Ohio. CDC examined whole-genome sequencing (WGS) data and identified six isolates from company A puppies in Florida that were highly related to an isolate from a company A customer in Ohio. This information prompted a multistate investigation by local and state health and agriculture departments and CDC to identify the outbreak source and prevent additional illness. Health officials from six states visited pet stores to collect puppy fecal samples, antibiotic records, and traceback information. Nationally, 118 persons, including 29 pet store employees, in 18 states were identified with illness onset during January 5, 2016–February 4, 2018. In total, six pet store companies were linked to the outbreak. Outbreak isolates were resistant by antibiotic susceptibility testing to all antibiotics commonly used to treat Campylobacter infections, including macrolides and quinolones. Store record reviews revealed that among 149 investigated puppies, 142 (95%) received one or more courses of antibiotics, raising concern that antibiotic use might have led to development of resistance. Public health authorities issued infection prevention recommendations to affected pet stores and recommendations for testing puppies to veterinarians. This outbreak demonstrates that puppies can be a source of multidrug-resistant Campylobacter infections in humans, warranting a closer look at antimicrobial use in the commercial dog industry.
Campylobacteriosis became a nationally notifiable condition in 2015, and many states routinely interview patients with campylobacteriosis.* For this investigation, a standardized, supplemental questionnaire was used by state and local health departments to collect dog exposure information from persons with Campylobacter infection who reported recent dog or pet store exposure during routine interview. A case definition relevant to this outbreak (Box) was developed to aid in case finding and characterization.
By February 28, 2018, a total of 118 persons meeting the case definition for Campylobacter infection, including 29 pet store employees, were reported from 18 states.† Age was available for 115 persons and ranged from <1 year to 85 years (median = 26 years); 74 of 115 (63%) infected persons were female. Among 107 persons for whom hospitalization information was available, 26 (24%) were hospitalized; no deaths occurred. In total, 105 of 106 (99%) infected persons reported dog exposure, including 101 (95%) who had contact with a pet store puppy (Table). Eight patients reported buying or having contact with puppies from five pet store companies other than company A (companies B–F), indicating that puppies became infected with Campylobacter before reaching pet stores.
State and local health and agriculture departments in four states (Kentucky, Ohio, Pennsylvania, and Wisconsin) visited 20 pet stores and collected antibiotic administration records for 154 puppies. Among 149 puppies with available information, 142 (95%) received one or more antibiotic courses before arriving or while at the store. Among 142 puppies that received antibiotics, treatment indication was available for 134 (94%); 78 (55%) treated puppies received antibiotics for prophylaxis only, 54 (38%) for prophylaxis and treatment, and two (1%) for treatment only. Median antibiotic treatment duration was 15 days (range = 2–67 days). Four antibiotics (metronidazole, sulfadimethoxine, doxycycline, and azithromycin) accounted for 81% of all antibiotics administered (Figure). Use of broad-spectrum antibiotics also was noted, including tetracyclines, quinolones, aminoglycosides, and chloramphenicol.
Stool specimens from infected persons or Campylobacter isolates were submitted to state public health laboratories. Health and agriculture officials from six states (Florida, Kansas, Kentucky, Ohio, Pennsylvania, and Wisconsin) visited 29 pet stores (27 company A and two company B) to collect puppy fecal samples. All company A and B stores in Ohio were visited, and a convenience sample of stores in other states was selected. Some states also requested fecal samples from patient households that had purchased puppies. Human stool specimens and puppy fecal samples underwent Campylobacter culture, and whole-genome multilocus sequence typing (wgMLST) was performed to compare genetic relatedness. Antibiotic susceptibility testing for nine antibiotics was performed by broth microdilution (Sensititer, Thermo Fisher Scientific) on selected isolates and interpreted using epidemiologic cutoff values established by the European Committee on Antimicrobial Susceptibility Testing. In this report, “resistant” refers to isolates with non–wild-type results (2). To explore pet food as a possible source of Campylobacter infection in puppies, dog food samples from company A and one person’s home were collected for culture.
Campylobacter jejuni isolates were obtained for 51 persons and 23 puppies. Outbreak isolates from 45 persons and 11 puppies grouped into three distinct clades by wgMLST. Six persons whose illnesses did not meet the case definition because their isolates were unrelated by wgMLST were excluded. Twelve puppy isolates were also unrelated to the outbreak by wgMLST. Two clades contained isolates from persons and puppies that were genetically related (≤32 alleles difference within each clade). The third clade contained six patient isolates that were related (≤30 alleles difference). Eighteen outbreak isolates (10 human and eight puppy) representing all three clades were selected for antibiotic susceptibility testing, and all were resistant to azithromycin, ciprofloxacin, clindamycin, erythromycin, nalidixic acid, telithromycin, and tetracycline. In addition, 16 of 18 isolates were resistant to gentamicin, and four of 18 were resistant to florfenicol. None of the cultures of 12 dog food samples yielded Campylobacter.
Records, including microchip identification numbers of puppies when available, were collected for puppies owned by infected persons and those sampled in stores. Microchips are implanted subcutaneously, usually before the puppy arrives at the store, and their corresponding identification numbers allowed investigators to trace puppies back to their breeders and distributors. Distributors are companies that purchase puppies wholesale from breeders and sell them to pet stores and other locations. Additional transport information was collected from stores when available. Practices identified during records review indicated that pet store puppies travel from breeders to distributors to stores by third-party transport companies. Information collected for eight puppies owned by infected persons and 20 puppies with fecal samples that were positive for Campylobacter jejuni traced back to 25 breeders and eight distributors. No single breeder, distributor, or transporter was identified as the infection source. However, potential for Campylobacter transmission among puppies exists because puppies from different breeders were commingled at distributors, during transport, and in stores.
Public Health Response
CDC developed educational materials on campylobacteriosis prevention. CDC and states shared these with pet industry partners, including retail pet stores. Educational messages focused on handwashing, separating human eating areas from animal areas, and using personal protective equipment correctly, such as wearing gloves when cleaning cages in pet stores. CDC posted an outbreak advisory online, which included information for clinicians and veterinarians recommending culture and antibiotic susceptibility testing to guide antibiotic treatment decisions (3).
Epidemiologic, laboratory, and traceback evidence indicates that puppies sold through the commercial dog industry, an uncommon source of Campylobacter outbreaks, were the source of a multistate outbreak of multidrug-resistant Campylobacter infections. This evidence, combined with the prolonged nature of the outbreak and the potential for puppy commingling, indicates a potential for continued transmission of multidrug-resistant Campylobacter industrywide, including at breeders, distributors, transporters, and stores, and ultimately in customers’ homes. Although the investigation is completed, the risk for multidrug-resistant Campylobacter transmission to employees and consumers continues.
Dog-associated Campylobacter outbreaks have been reported previously, but those outbreaks involved fewer illnesses, and the isolates were not multidrug-resistant (4–6). The investigation of this outbreak revealed widespread administration of multiple antibiotic classes, including all classes to which the outbreak Campylobacter strains were resistant. Hygiene and animal husbandry practices can reduce the need for antibiotics and decrease transmission of Campylobacter between animals and from animals to humans (7). Adherence to antibiotic stewardship practices in these settings might reduce the selection of highly drug-resistant Campylobacter. Implementation of antibiotic stewardship principles and practices in the commercial dog industry is needed.
Clinicians should consider that persons can acquire Campylobacter infections, including multidrug-resistant infections, from puppies. If antibiotics are indicated, consider stool culture and antibiotic susceptibility testing. Pet stores, commercial distributors, transporters, and breeders should ensure that existing biosecurity measures are sufficient to reduce ongoing risk for Campylobacter transmission between puppies and humans. Pet stores should provide employee and customer education and training on handwashing and provide employees with personal protective equipment when cleaning animal areas (8). Educational information§ that veterinarians and pet stores provide to pet owners could include information on reducing the risk for pathogen transmission. Finally, antibiotics should only be administered under veterinary supervision with a valid veterinary-client-patient relationship, consistent with existing stewardship principles.¶
Karen Baransi, Jason Herr, Larry King, Glen McGillivary, Jade Mowery, Justin Seikel, Ohio Department of Health; Bev Byrum, Ohio Department of Agriculture; Nancy Pickens, John Nasir, Matthew Schimenti, Florida Department of Health; Ashley Vineyard, Heyda Rodriguez, Florida Department of Health in Orange County; Nelly Amador Jehn, Florida Department of Agriculture and Consumer Services; Renate Reimschuessel, Food and Drug Administration Veterinary Laboratory Investigation and Response Network, Washington, DC; Michael Hughes, Ellyn Marder, Meseret Birhane, Hayat Caidi, Beth Karp, Ian Plumb, Janet Pruckler, Jared Reynolds, Kaitlin Tagg, Jean Whichard, CDC.
Corresponding author: Martha P. Montgomery, MMontgomery4@cdc.gov, 404-718-7126.
1Ohio Department of Health; 2Epidemic Intelligence Service, CDC; 3Division of Foodborne, Waterborne, and Environmental Diseases, National Center for Emerging and Zoonotic Infectious Diseases, CDC; 4Oak Ridge Institute for Science and Education, Oak Ridge, Tennessee; 5Caitta, Inc., Herndon, Virginia; 6Atlanta Research and Education Foundation, Atlanta, Georgia; 7Ohio Department of Agriculture; 8IHRC, Inc., Atlanta, Georgia; 9Florida Department of Health in Orange County; 10Florida Department of Health.
All authors have completed and submitted the ICMJE form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
† Connecticut (two patients), Florida (20), Georgia (five), Illinois (11), Kansas (seven), Massachusetts (two), Maryland (five), Michigan (one), Missouri (two), New Hampshire (two), New York (two), Ohio (34), Oklahoma (one), Pennsylvania (six), Tennessee (two), Utah (four), Wisconsin (nine), and Wyoming (three).
¶ https://www.avma.org/KB/Policies/Pages/Antimicrobial-Stewardship-Definition-and-Core-Principles.aspxexternal icon.
- Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States—major pathogens. Emerg Infect Dis 2011;17:7–15. CrossRefexternal icon PubMedexternal icon
- CDC. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): 2014 human isolates surveillance report for 2014. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https://www.cdc.gov/narms/pdf/2014-Annual-Report-narms-508c.pdfpdf icon
- CDC. Campylobacter (campylobacteriosis): multistate outbreak of multidrug-resistant Campylobacter infections linked to contact with pet store puppies. Atlanta, GA: US Department of Health and Human Services, CDC; 2018. https://www.cdc.gov/campylobacter/outbreaks/puppies-9-17/index.html
- Blaser M, Cravens J, Powers BW, Wang WL. Campylobacter enteritis associated with canine infection. Lancet 1978;2:979–81. CrossRefexternal icon PubMedexternal icon
- Campagnolo ER, Philipp LM, Long JM, Hanshaw NL. Pet-associated campylobacteriosis: a persisting public health concern. Zoonoses Public Health 2018;65:304–11. CrossRefexternal icon PubMedexternal icon
- Moffatt C, Appuhamy R, Andrew W, Wynn S, Roberts J, Kennedy K. An assessment of risk posed by a Campylobacter-positive puppy living in an Australian residential aged-care facility. Western Pac Surveill Response J 2014;5:1–6. CrossRefexternal icon PubMedexternal icon
- Kimman T, Hoek M, de Jong MCM. Assessing and controlling health risks from animal husbandry. NJAS Wagening J Life Sci 2013;66:7–14. CrossRefexternal icon
- National Association of State Public Health Veterinarians, Veterinary Infection Control Committee. Compendium of veterinary standard precautions for zoonotic disease prevention in veterinary personnel. Schaumburg, IL: American Veterinary Medical Association; 2015. https://www.avma.org/KB/Policies/Pages/Compendium-of-Veterinary-Standard-Precautions-for-Zoonotic-Disease-Prevention-in-Veterinary-Personnel.aspxexternal icon
BOX. Case definition for multidrug-resistant Campylobacter jejuni outbreak linked to puppy exposure — United States, 2016–2018*
Campylobacteriosis in a patient with onset during January 1, 2016–February 28, 2018, who had either
- A clinical isolate closely related* to the outbreak strains by whole-genome sequencing (WGS), or
- Other laboratory evidence (culture or culture-independent diagnostic testing) of Campylobacter infection and worked in, visited, or had contact with a puppy from a pet store within 7 days before illness onset.
An illness compatible with Campylobacter infection in a patient who had worked in, visited, or had contact with a puppy from a pet store within 7 days before illness onset, but without laboratory confirmation of Campylobacter infection.
Exposure criteria met, but isolate unrelated to the outbreak strains by WGS.
* Relatedness of outbreak strains was determined by whole-genome multilocus sequence typing (wgMLST). Because no published wgMLST cutoff values exist, genetic relatedness was determined based on epidemiologic concordance and comparison with background Campylobacter jejuni isolates.
FIGURE. Number of days of antibiotics administered to 149 pet store puppies* assessed during a multidrug-resistant Campylobacter jejuni outbreak, by type of antibiotic — United States, 2016–2018
Abbreviation: SMX-TMP = sulfamethoxazole-trimethoprim.
* Excludes five puppies with missing information on number of days treated.
Suggested citation for this article: Montgomery MP, Robertson S, Koski L, et al. Multidrug-Resistant Campylobacter jejuni Outbreak Linked to Puppy Exposure — United States, 2016–2018. MMWR Morb Mortal Wkly Rep 2018;67:1032–1035. DOI: http://dx.doi.org/10.15585/mmwr.mm6737a3external icon.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to firstname.lastname@example.org.